You are here

  • Home
  • Archive
  • Volume 15, Issue Suppl 2
  • 000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY

Article Text

Article menu
Download PDFPDF
Poster Group 3A – Wednesday, September 28, 2005
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY

https://doi.org/10.1136/ijgc-00009577-200509001-00404

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.